MAD2L1 and hepatocellular carcinoma: As shown in Figure 7, high expression of RRM2, MELK, KIF23, NCAPG, BUB1B, AURKB, CCNB1, KIF20A, CCNA2, TTK, PBK, TOP2A, CDK1, MAD2L1, BIRC5, ASPM, CDCA8, CENPF, KIF11, and DLGAP5 indicated significantly unfavorable overall survival in patients with HCC.